Projected Growth in FDA-Approved Artificial Intelligence Products Given Venture Capital Funding
Medical imaging accounts for 85% of digital health’s venture capital funding. As funding grows, it is expected that artificial intelligence (AI) products will increase commensurately. The study’s objective is to project the number of new AI products given the statistical association between historical funding and FDA-approved AI products. Full Article
Nicole K. McNabb, BS Eric W. Christensen, PhD Elizabeth Y. Rula, PhD Laura Coombs, PhD Keith Dreyer, DO, PhD Christoph Wald, MD Christopher Treml, MS. 2023. "Projected Growth in FDA-Approved Artificial Intelligence Products Given Venture Capital Funding," Journal of American College of Radiology (JACR)